Integra Lifesciences Holdings (IART) Change in Receivables (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Change in Receivables of $3.0 million for Q2 2026, up 122.29% sequentially from -$13.6 million in Q1 2026, and down 89.14% YoY from $28.0 million in Q2 2025.
Integra Lifesciences Holdings (IART) Change in Receivables (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Change in Receivables for 18 years, with the latest figure at $3.0 million in Q2 2026.
- Quarterly Change in Receivables fell 89.14% year-over-year to $3.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$16.7 million (down 280.04% YoY) and the FY2025 annual result came in at $485000.0, up 106.56% from the prior year.
- Change in Receivables rose to $3.0 million in Q2 2026 per IART's latest filing, from -$13.6 million in the prior quarter.
- Over five years, Change in Receivables peaked at $31.5 million in Q4 2024 and troughed at -$28.8 million in Q3 2024.
- A 5-year average of $655277.8 and a median of $3.1 million in 2022 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 6784.68% in 2024, down 12734.82% in 2024.
- Over 5 years, Change in Receivables stood at $10.0 million in 2022, then slumped by 95.45% to $457000.0 in 2023, then soared by 6784.68% to $31.5 million in 2024, then plunged by 47.71% to $16.5 million in 2025, then tumbled by 81.52% to $3.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $3.0 million, -$13.6 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Integra Lifesciences Holdings | 1.30 Bn | 1.03 Bn | 219.74 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.04 Mn |
| Jun 30, 2026 | 3.04 Mn |
| Mar 31, 2026 | -13.65 Mn |
| Mar 31, 2026 | -13.65 Mn |
| Dec 31, 2025 | 16.45 Mn |
| Dec 31, 2025 | 16.45 Mn |
| Sep 30, 2025 | -22.51 Mn |
| Sep 30, 2025 | -22.51 Mn |
| Jun 30, 2025 | 27.99 Mn |
| Jun 30, 2025 | 27.99 Mn |
| Mar 31, 2025 | -21.45 Mn |
| Mar 31, 2025 | -21.45 Mn |
| Dec 31, 2024 | 31.46 Mn |
| Dec 31, 2024 | 31.46 Mn |
| Sep 30, 2024 | -28.75 Mn |
| Sep 30, 2024 | -28.75 Mn |
| Jun 30, 2024 | 6.72 Mn |
| Jun 30, 2024 | 6.72 Mn |
| Mar 31, 2024 | -16.83 Mn |
| Mar 31, 2024 | -16.83 Mn |